FIS Options Turn Defensive as Analysts Trim Targets Ahead of Q3 Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Fidelity National Information Services reports third-quarter results on November 3, and the clearest signal going into the print is in options: put demand has jumped sharply relative to its recent norm, even as the stock has outperformed its peers through October.
The put/call ratio closed at 0.71 on October 30, nearly two standard deviations above its 20-day average of 0.61. That is the most defensive options positioning FIS has seen in months, with the ratio approaching levels not seen since September, when it briefly touched its 52-week high of 0.97. The move is notable against a backdrop where the stock itself has recovered: FIS rose 3.4% on Friday and is up 2.7% on the week, outpacing a peer group that fell a median 5.2% over the same period. Fiserv dropped 4.6% on the week, Euronet fell 7.0%, and Marqeta lost 6.6%. That FIS held up while the broader payments space sold off is notable, though the options market is hedging against whether the strength can survive the earnings release.
Short interest tells a calmer story. At roughly 3.9% of the free float, the position is not large, though it has climbed about 29% over the past month in share terms, a steady build rather than a squeeze setup. Borrow availability remains extremely loose, with over 5,800% availability, meaning shares are plentiful for anyone wishing to add to the short. Cost to borrow is just 0.40%, near its lowest level of the year. There is no mechanical pressure on short sellers here.
The analyst community has moved in one direction over the past several weeks: lower. Goldman Sachs cut its target from $52 to $44 on October 13 while keeping its Buy rating. Citigroup and Barclays also trimmed targets in mid-October. Truist cut to $37 on October 23, the most recent action on record. The mean target across the Street is $47.04, against a current price of $38.55, implying roughly 22% upside on the consensus view. The debate is less about direction than execution. The bull case points to a rebound in Banking segment activity, improving EBITDA margins with roughly 150 basis points of year-on-year expansion expected in the fourth quarter, and strengthening new sales momentum. Bears point to competition, integration risk, and the sensitivity of FIS's revenue to banking industry consolidation and technology spending decisions that can shift quickly.
One institutional development worth noting: Capital Research and Management added over 20 million shares in the most recent reported quarter, lifting its stake to 7.6% of shares outstanding. That is a material addition for a single investor. Dodge & Cox remains the largest declared holder at 9.5%, unchanged on the quarter. No Schedule 13D activist filer is on the register.
The November 3 print is ultimately a test of whether the margin recovery management has been guiding toward is translating into reported figures, and whether the Banking segment momentum has held through the quarter as the company claims.
Stocks in this article
See the live data behind this article on ORTEX.
Open FIS on ORTEX →How this article was generated
- Generated
- 31 Oct 2026, 04:19
- Data as of
- 31 Oct 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.